Cargando…
A novel drug for uncomplicated malaria: targeted high throughput screening (HTS) against the type II NADH:ubiquinone oxidoreductase (PfNdh2) of Plasmodium falciparum
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2963205/ http://dx.doi.org/10.1186/1475-2875-9-S2-I14 |
| _version_ | 1782189242471940096 |
|---|---|
| author | Ward, Steve A Fisher, Nicholas Hill, Alasdair Mbekeani, Alison Shone, Alison Nixon, Gemma Stocks, Paul Gibbons, Peter Amewu, Richard Hong, David W Barton, Victoria Pidathala, Chandra Chadwick, James Le Pensee, Louise Warman, Ashley Sharma, Raman Berry, Neil G O'Neill, Paul M Biagini, Giancarlo A |
| author_facet | Ward, Steve A Fisher, Nicholas Hill, Alasdair Mbekeani, Alison Shone, Alison Nixon, Gemma Stocks, Paul Gibbons, Peter Amewu, Richard Hong, David W Barton, Victoria Pidathala, Chandra Chadwick, James Le Pensee, Louise Warman, Ashley Sharma, Raman Berry, Neil G O'Neill, Paul M Biagini, Giancarlo A |
| author_sort | Ward, Steve A |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-2963205 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2010 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-29632052010-10-26 A novel drug for uncomplicated malaria: targeted high throughput screening (HTS) against the type II NADH:ubiquinone oxidoreductase (PfNdh2) of Plasmodium falciparum Ward, Steve A Fisher, Nicholas Hill, Alasdair Mbekeani, Alison Shone, Alison Nixon, Gemma Stocks, Paul Gibbons, Peter Amewu, Richard Hong, David W Barton, Victoria Pidathala, Chandra Chadwick, James Le Pensee, Louise Warman, Ashley Sharma, Raman Berry, Neil G O'Neill, Paul M Biagini, Giancarlo A Malar J Invited Speaker Presentation BioMed Central 2010-10-20 /pmc/articles/PMC2963205/ http://dx.doi.org/10.1186/1475-2875-9-S2-I14 Text en Copyright ©2010 Ward et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Invited Speaker Presentation Ward, Steve A Fisher, Nicholas Hill, Alasdair Mbekeani, Alison Shone, Alison Nixon, Gemma Stocks, Paul Gibbons, Peter Amewu, Richard Hong, David W Barton, Victoria Pidathala, Chandra Chadwick, James Le Pensee, Louise Warman, Ashley Sharma, Raman Berry, Neil G O'Neill, Paul M Biagini, Giancarlo A A novel drug for uncomplicated malaria: targeted high throughput screening (HTS) against the type II NADH:ubiquinone oxidoreductase (PfNdh2) of Plasmodium falciparum |
| title | A novel drug for uncomplicated malaria: targeted high throughput screening (HTS) against the type II NADH:ubiquinone oxidoreductase (PfNdh2) of Plasmodium falciparum |
| title_full | A novel drug for uncomplicated malaria: targeted high throughput screening (HTS) against the type II NADH:ubiquinone oxidoreductase (PfNdh2) of Plasmodium falciparum |
| title_fullStr | A novel drug for uncomplicated malaria: targeted high throughput screening (HTS) against the type II NADH:ubiquinone oxidoreductase (PfNdh2) of Plasmodium falciparum |
| title_full_unstemmed | A novel drug for uncomplicated malaria: targeted high throughput screening (HTS) against the type II NADH:ubiquinone oxidoreductase (PfNdh2) of Plasmodium falciparum |
| title_short | A novel drug for uncomplicated malaria: targeted high throughput screening (HTS) against the type II NADH:ubiquinone oxidoreductase (PfNdh2) of Plasmodium falciparum |
| title_sort | novel drug for uncomplicated malaria: targeted high throughput screening (hts) against the type ii nadh:ubiquinone oxidoreductase (pfndh2) of plasmodium falciparum |
| topic | Invited Speaker Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2963205/ http://dx.doi.org/10.1186/1475-2875-9-S2-I14 |
| work_keys_str_mv | AT wardstevea anoveldrugforuncomplicatedmalariatargetedhighthroughputscreeninghtsagainstthetypeiinadhubiquinoneoxidoreductasepfndh2ofplasmodiumfalciparum AT fishernicholas anoveldrugforuncomplicatedmalariatargetedhighthroughputscreeninghtsagainstthetypeiinadhubiquinoneoxidoreductasepfndh2ofplasmodiumfalciparum AT hillalasdair anoveldrugforuncomplicatedmalariatargetedhighthroughputscreeninghtsagainstthetypeiinadhubiquinoneoxidoreductasepfndh2ofplasmodiumfalciparum AT mbekeanialison anoveldrugforuncomplicatedmalariatargetedhighthroughputscreeninghtsagainstthetypeiinadhubiquinoneoxidoreductasepfndh2ofplasmodiumfalciparum AT shonealison anoveldrugforuncomplicatedmalariatargetedhighthroughputscreeninghtsagainstthetypeiinadhubiquinoneoxidoreductasepfndh2ofplasmodiumfalciparum AT nixongemma anoveldrugforuncomplicatedmalariatargetedhighthroughputscreeninghtsagainstthetypeiinadhubiquinoneoxidoreductasepfndh2ofplasmodiumfalciparum AT stockspaul anoveldrugforuncomplicatedmalariatargetedhighthroughputscreeninghtsagainstthetypeiinadhubiquinoneoxidoreductasepfndh2ofplasmodiumfalciparum AT gibbonspeter anoveldrugforuncomplicatedmalariatargetedhighthroughputscreeninghtsagainstthetypeiinadhubiquinoneoxidoreductasepfndh2ofplasmodiumfalciparum AT amewurichard anoveldrugforuncomplicatedmalariatargetedhighthroughputscreeninghtsagainstthetypeiinadhubiquinoneoxidoreductasepfndh2ofplasmodiumfalciparum AT hongdavidw anoveldrugforuncomplicatedmalariatargetedhighthroughputscreeninghtsagainstthetypeiinadhubiquinoneoxidoreductasepfndh2ofplasmodiumfalciparum AT bartonvictoria anoveldrugforuncomplicatedmalariatargetedhighthroughputscreeninghtsagainstthetypeiinadhubiquinoneoxidoreductasepfndh2ofplasmodiumfalciparum AT pidathalachandra anoveldrugforuncomplicatedmalariatargetedhighthroughputscreeninghtsagainstthetypeiinadhubiquinoneoxidoreductasepfndh2ofplasmodiumfalciparum AT chadwickjames anoveldrugforuncomplicatedmalariatargetedhighthroughputscreeninghtsagainstthetypeiinadhubiquinoneoxidoreductasepfndh2ofplasmodiumfalciparum AT lepenseelouise anoveldrugforuncomplicatedmalariatargetedhighthroughputscreeninghtsagainstthetypeiinadhubiquinoneoxidoreductasepfndh2ofplasmodiumfalciparum AT warmanashley anoveldrugforuncomplicatedmalariatargetedhighthroughputscreeninghtsagainstthetypeiinadhubiquinoneoxidoreductasepfndh2ofplasmodiumfalciparum AT sharmaraman anoveldrugforuncomplicatedmalariatargetedhighthroughputscreeninghtsagainstthetypeiinadhubiquinoneoxidoreductasepfndh2ofplasmodiumfalciparum AT berryneilg anoveldrugforuncomplicatedmalariatargetedhighthroughputscreeninghtsagainstthetypeiinadhubiquinoneoxidoreductasepfndh2ofplasmodiumfalciparum AT oneillpaulm anoveldrugforuncomplicatedmalariatargetedhighthroughputscreeninghtsagainstthetypeiinadhubiquinoneoxidoreductasepfndh2ofplasmodiumfalciparum AT biaginigiancarloa anoveldrugforuncomplicatedmalariatargetedhighthroughputscreeninghtsagainstthetypeiinadhubiquinoneoxidoreductasepfndh2ofplasmodiumfalciparum AT wardstevea noveldrugforuncomplicatedmalariatargetedhighthroughputscreeninghtsagainstthetypeiinadhubiquinoneoxidoreductasepfndh2ofplasmodiumfalciparum AT fishernicholas noveldrugforuncomplicatedmalariatargetedhighthroughputscreeninghtsagainstthetypeiinadhubiquinoneoxidoreductasepfndh2ofplasmodiumfalciparum AT hillalasdair noveldrugforuncomplicatedmalariatargetedhighthroughputscreeninghtsagainstthetypeiinadhubiquinoneoxidoreductasepfndh2ofplasmodiumfalciparum AT mbekeanialison noveldrugforuncomplicatedmalariatargetedhighthroughputscreeninghtsagainstthetypeiinadhubiquinoneoxidoreductasepfndh2ofplasmodiumfalciparum AT shonealison noveldrugforuncomplicatedmalariatargetedhighthroughputscreeninghtsagainstthetypeiinadhubiquinoneoxidoreductasepfndh2ofplasmodiumfalciparum AT nixongemma noveldrugforuncomplicatedmalariatargetedhighthroughputscreeninghtsagainstthetypeiinadhubiquinoneoxidoreductasepfndh2ofplasmodiumfalciparum AT stockspaul noveldrugforuncomplicatedmalariatargetedhighthroughputscreeninghtsagainstthetypeiinadhubiquinoneoxidoreductasepfndh2ofplasmodiumfalciparum AT gibbonspeter noveldrugforuncomplicatedmalariatargetedhighthroughputscreeninghtsagainstthetypeiinadhubiquinoneoxidoreductasepfndh2ofplasmodiumfalciparum AT amewurichard noveldrugforuncomplicatedmalariatargetedhighthroughputscreeninghtsagainstthetypeiinadhubiquinoneoxidoreductasepfndh2ofplasmodiumfalciparum AT hongdavidw noveldrugforuncomplicatedmalariatargetedhighthroughputscreeninghtsagainstthetypeiinadhubiquinoneoxidoreductasepfndh2ofplasmodiumfalciparum AT bartonvictoria noveldrugforuncomplicatedmalariatargetedhighthroughputscreeninghtsagainstthetypeiinadhubiquinoneoxidoreductasepfndh2ofplasmodiumfalciparum AT pidathalachandra noveldrugforuncomplicatedmalariatargetedhighthroughputscreeninghtsagainstthetypeiinadhubiquinoneoxidoreductasepfndh2ofplasmodiumfalciparum AT chadwickjames noveldrugforuncomplicatedmalariatargetedhighthroughputscreeninghtsagainstthetypeiinadhubiquinoneoxidoreductasepfndh2ofplasmodiumfalciparum AT lepenseelouise noveldrugforuncomplicatedmalariatargetedhighthroughputscreeninghtsagainstthetypeiinadhubiquinoneoxidoreductasepfndh2ofplasmodiumfalciparum AT warmanashley noveldrugforuncomplicatedmalariatargetedhighthroughputscreeninghtsagainstthetypeiinadhubiquinoneoxidoreductasepfndh2ofplasmodiumfalciparum AT sharmaraman noveldrugforuncomplicatedmalariatargetedhighthroughputscreeninghtsagainstthetypeiinadhubiquinoneoxidoreductasepfndh2ofplasmodiumfalciparum AT berryneilg noveldrugforuncomplicatedmalariatargetedhighthroughputscreeninghtsagainstthetypeiinadhubiquinoneoxidoreductasepfndh2ofplasmodiumfalciparum AT oneillpaulm noveldrugforuncomplicatedmalariatargetedhighthroughputscreeninghtsagainstthetypeiinadhubiquinoneoxidoreductasepfndh2ofplasmodiumfalciparum AT biaginigiancarloa noveldrugforuncomplicatedmalariatargetedhighthroughputscreeninghtsagainstthetypeiinadhubiquinoneoxidoreductasepfndh2ofplasmodiumfalciparum |